02 Feb 2023. ART-TG is recruiting a head for its Bioproduction unit, a great opportunity to contribute to exciting research in gene...

Visite de Sylvie Retailleau, Ministre de la Recherche, de l'Enseignement Supérieur et de l'Innovatio, accompagnée de Gilles Bloch,...

Presentation of poster 504 by Dr. J. Doms ART-TG at ESGCT Vaccine technologies and Infectious Diseases. Rrom Pentland 8:30-10:40 "A...

ART-TG contributed to lentiviral standardization, improving analytical methods. Corre et al. Gene Therapy (2022) 29:536–543 #genetherapy,...

ART-TG contributed to this recent review by Donnadieu et al. in Journal for Immunotherapy of Cancer, https://jitc.bmj.com/content/10/5/e0...

ART-TG recruits engineers and managers for its projects. Please check the JOBS annoucements

ASMA project: Acoustic Solutions for Manufacturing Advanced Therapies

https://www.youtube.com/watch?v=6jzlHz2Vbrw

ART-TG is pleased to announce its collaboration with WhiteLab Genomics on the development of artificial intelligence to improve the...

. ..of gene therapies for severe immune deficiencies. In this consortium, ART-TG will bring its expertise on the quality control of...

Development of CAR-T cell therapies to fight cancer. Read the press release.

Gaele RIGAULT has been appointed to develop the partnerships and business of MAGENTA, the industrial integrator in cell and gene therapy.

Best wishes for a healthy new year 2021 and for the progress of science !

Organisé par le LEEM, 3 tables rondes font le point sur les partenariats public privé. Avec la participation d'A. Galy. Les échanges...

ART-TG and VRI teams have received 3-year funding from ANRS to develop new HIV vaccines based on CRISPR genome editing of B cells.

ART-TG et Cithera joignent leurs expertises en thérapie cellulaire et génique pour fonder MAGENTA qui reçoit le label "Integrateur...

ART-TG and MAGENTA are presented at the Bioproduction Congress organized by Mabdesign.